A Study to Evaluate the Safety and Tolerability of GEN6050X in Duchenne Muscular Dystrophy.
Clinical trial NCT06392724 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06392724
- Sponsor
- Peking Union Medical College Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-05
- Primary completion
- 2025-12-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.